Pliant Therapeutics, Inc.
PLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $797,294 | $1,063,403 | $812,168 | $483,927 |
| - Cash | $71,188 | $63,234 | $33,685 | $51,665 |
| + Debt | $60,192 | $11,372 | $15,815 | $7,194 |
| Enterprise Value | $786,298 | $1,011,541 | $794,298 | $439,456 |
| Revenue | $0 | $1,580 | $9,685 | $7,572 |
| % Growth | -100% | -83.7% | 27.9% | – |
| Gross Profit | $0 | $1,580 | $9,685 | $7,572 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$205,155 | -$158,228 | -$118,849 | -$95,728 |
| % Margin | – | -10,014.4% | -1,227.1% | -1,264.2% |
| Net Income | -$210,304 | -$161,336 | -$123,321 | -$97,263 |
| % Margin | – | -10,211.1% | -1,273.3% | -1,284.5% |
| EPS Diluted | -3.47 | -2.75 | -2.94 | -2.71 |
| % Growth | -26.2% | 6.5% | -8.5% | – |
| Operating Cash Flow | -$155,503 | -$116,361 | -$94,631 | -$75,443 |
| Capital Expenditures | -$3,848 | -$921 | -$1,760 | -$1,953 |
| Free Cash Flow | -$159,351 | -$117,282 | -$96,391 | -$77,396 |